DeNDRoN: Targets for 2010-2015
The key to DeNDRoN’s success will lie in its integration in the organisations and acceptance by the individuals from which the network is composed. The purpose of the Co-ordinating Centre and Local Research Networks is to provide the leadership and administration necessary to bring the network together; to support the integration of health research and patient care; and to co-ordinate the development of capacity and expertise within the constituent parts of the network necessary to improve the quality and speed of research they support.
Key network targets
# |
Measure |
Target |
Aspirational target |
Active management of the network |
|||
1.1 |
Percentage of relevant NHS organisations referring patients to portfolio studies |
20% increase on baseline |
90% of all relevant NHS organisations |
1.2 |
Percentage of relevant consultants referring to portfolio studies |
20% increase on baseline |
50% of all consultants |
1.3 |
Percentage of cases consented onto the DeNDRoN RAFT (Recruitment And Feasibility Tool) |
10% |
30% |
Development and delivery of a balanced portfolio |
|||
2.1 |
Number of large scale, multicentre studies that are funded |
50% increase on baseline |
100% increase on baseline |
2.2 |
Size of portfolio |
20% increase on baseline |
100% increase on baseline |
2.3 |
Percentage of non-commercial studies completing on target to predefined timelines |
80% |
90% |
2.4 |
Number of multi-disciplinary research sites capable of delivering complex interventional trials |
20% increase on baseline |
50% increase on baseline |
2.5 |
Number of patients in non-commercial studies |
100% increase on baseline |
150% increase on baseline |
Meeting the needs of industry |
|||
3.1 |
Percentage of studies delivered on target to predefined timelines |
80% |
90% |
3.2 |
Number of commercial PIs |
50% increase on baseline |
100% increase on baseline |
3.3 |
Number of patients in commercial trials |
100% increase on baseline |
150% increase on baseline |